|
Market Closed -
OTC Markets
23:59:56 17/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1655 USD | -0.05% |
|
+0.15% | -27.65% |
Evolution of the Average Target: Northwest Biotherapeutics, Inc.
Evolution of the Target Price: Northwest Biotherapeutics, Inc.
Changes in Analyst Recommendations: Northwest Biotherapeutics, Inc.
ec3aff1.5itHHanThoDQkILQdwJLSofUx39eev7DXkRBwTSl1O0.nGM1VtGw0NGH5a-bM1MMecmWghU9KpiJOwkY-XHWp6W1Gz0uzJ3A0b7x6Q~20f365ce9243e36f136b8c735df85338
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +504.23% | |||
| +16.56% | |||||
| +18.28% | |||||
| +60.95% | |||||
| +20.37% | |||||
| +9.35% | |||||
| +16.93% | |||||
| -8.21% | |||||
| +64.19% | |||||
| +26.88% | |||||
| Average | +72.95% | |||||
| Weighted average by Cap. | +23.57% |
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1655USD
Average target price
1.000USD
Spread / Average Target
+504.23%
High Price Target
1.000USD
Spread / Highest target
+504.23%
Low Price Target
1.000USD
Spread / Lowest Target
+504.23%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- NWBO Stock
- Consensus Northwest Biotherapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
